A new antibiotic for treating urinary tract infections (UTIs) has been given the green light by UK regulators, for the first time in almost three decades.

Gepotidacin, also known as Blujepa, can be used by women in the UK who suffer recurring infections, the Medicines and Healthcare products Regulatory Agency (MHRA) said.

Read more in the full article.